Literature DB >> 9176895

Trabecular meshwork phagocytosis in glaucomatous eyes.

Y Matsumoto1, D H Johnson.   

Abstract

Trabecular meshwork cells are actively phagocytic and may function to keep the drainage pathways free of cellular debris, pigment and other material. A decrease in phagocytic capacity has been proposed in the pathogenesis of glaucoma. This study was performed to compare the phagocytic capability of the human trabecular meshwork in glaucomatous and normal human eyes. The anterior segments of 6 donors with glaucoma (primary open-angle glaucoma, POAG: 5 donors; pseudoexfoliative glaucoma, PEX: 1 donor) and 6 normal donors were placed in perfusion organ culture. During the final 24 h of culture, latex microspheres, labeled with FITC and coated with antibodies, were perfused into the anterior segments. Eyes were then fixed, the trabecular meshworks were treated with a rhodamine-labeled secondary antibody, sectioned and the number of ingested beads determined with the laser scanning confocal microscope. Nuclei were quantitated and used to calculate the phagocytic index of each eye (number of ingested beads/number of nuclei). Anterior segments of glaucomatous donors were cultured for 1-3 days, as a preliminary culture study had revealed that culture of glaucomatous anterior segments is successful in only 50% when cultured for 21 days. Specimens of normal donors were cultured for 21 days. Ingested beads appeared green and could be differentiated from noningested beads, which appeared red, using appropriate wavelengths of the laser. Bead ingestion was confirmed with electron microscopy and the use of a secondary antibody labeled with horseradish peroxidase. Ingestion rates appeared similar among all three groups of eyes: POAG, 3.8 beads/cell; PEX, 3.3 beads/cell; normal, 3.5 beads/ cell. No evidence of significant migration or loss of trabecular cells was noted. Cell counts were not significantly different: POAG, 127 +/- 40 cells/section; normals, 136 +/- 49 cells/section. In conclusion, the phagocytic ability of the trabecular meshwork appears similar between eyes with POAG and normal eyes in perfusion organ culture. Cell loss after phagocytosis was not observed in these single-exposure experiments.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9176895     DOI: 10.1159/000310782

Source DB:  PubMed          Journal:  Ophthalmologica        ISSN: 0030-3755            Impact factor:   3.250


  17 in total

Review 1.  The role of integrins in the trabecular meshwork.

Authors:  Debjani Gagen; Jennifer A Faralli; Mark S Filla; Donna M Peters
Journal:  J Ocul Pharmacol Ther       Date:  2013-11-23       Impact factor: 2.671

2.  Genetic Heritability of Pigmentary Glaucoma and Associations With Other Eye Phenotypes.

Authors:  Mark J Simcoe; Nicole Weisschuh; Bernd Wissinger; Pirro G Hysi; Christopher J Hammond
Journal:  JAMA Ophthalmol       Date:  2020-03-01       Impact factor: 7.389

3.  Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor beta.

Authors:  Xinyu Zhang; Cherie M Ognibene; Abbot F Clark; Thomas Yorio
Journal:  Exp Eye Res       Date:  2006-11-28       Impact factor: 3.467

4.  Bioengineered glaucomatous 3D human trabecular meshwork as an in vitro disease model.

Authors:  Karen Y Torrejon; Ellen L Papke; Justin R Halman; Judith Stolwijk; Cula N Dautriche; Magnus Bergkvist; John Danias; Susan T Sharfstein; Yubing Xie
Journal:  Biotechnol Bioeng       Date:  2015-12-30       Impact factor: 4.530

Review 5.  The many faces of the trabecular meshwork cell.

Authors:  W Daniel Stamer; Abbot F Clark
Journal:  Exp Eye Res       Date:  2016-07-19       Impact factor: 3.467

Review 6.  The role of integrins in glaucoma.

Authors:  Mark S Filla; Jennifer A Faralli; Jennifer L Peotter; Donna M Peters
Journal:  Exp Eye Res       Date:  2016-05-13       Impact factor: 3.467

Review 7.  Molecular Insights into Myocilin and Its Glaucoma-Causing Misfolded Olfactomedin Domain Variants.

Authors:  Raquel L Lieberman; Minh Thu Ma
Journal:  Acc Chem Res       Date:  2021-04-13       Impact factor: 24.466

Review 8.  Molecular Genetics of Pigment Dispersion Syndrome and Pigmentary Glaucoma: New Insights into Mechanisms.

Authors:  Adrian A Lahola-Chomiak; Michael A Walter
Journal:  J Ophthalmol       Date:  2018-03-26       Impact factor: 1.909

9.  BMP and Activin Membrane Bound Inhibitor Regulates the Extracellular Matrix in the Trabecular Meshwork.

Authors:  Humberto Hernandez; J Cameron Millar; Stacy M Curry; Abbot F Clark; Colleen M McDowell
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-04-01       Impact factor: 4.799

10.  A porcine ex vivo model of pigmentary glaucoma.

Authors:  Yalong Dang; Susannah Waxman; Chao Wang; Ralitsa T Loewen; Ming Sun; Nils A Loewen
Journal:  Sci Rep       Date:  2018-04-03       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.